Analysis and Commentary 4/3/21 Analysis and Commentary 4/3/21 Legal Limitations on Appointment of New FDA Commissioner Read More Analysis and Commentary 1/10/20 Analysis and Commentary 1/10/20 FDA Is Its People Read More 11/21/19 11/21/19 Senate HELP Committee Interviews Stephen Hahn, MD Read More 1/7/19 1/7/19 Alliance Releases FDA Shutdown Toolkit Read More Analysis and Commentary 9/29/17 Analysis and Commentary 9/29/17 Plus ça Change, Plus c'est la Même Chose Read More Analysis and Commentary 7/27/17 Analysis and Commentary 7/27/17 Challenges and Threats to FDA Resources: An Update Read More Advocacy at a Glance 7/8/16 Advocacy at a Glance 7/8/16 Advocacy at a Glance Read More Analysis and Commentary 10/30/15 Analysis and Commentary 10/30/15 So ... How Do We Help FDA Get a Fair Cut of the Extra $40 Billion? Read More Advocacy at a Glance 10/9/15 Advocacy at a Glance 10/9/15 Will FSMA Make a Difference and more Read More Advocacy at a Glance 10/2/15 Advocacy at a Glance 10/2/15 DA Science Board Report Calls for Funding to Meet Responsibilities and more Read More Analysis and Commentary 5/1/15 Analysis and Commentary 5/1/15 FDA Funding and 21st Century Cures Read More Analysis and Commentary 2/6/15 Analysis and Commentary 2/6/15 POTUS's FY 16 Budget Request ... On Careful Reflection Read More
Analysis and Commentary 4/3/21 Analysis and Commentary 4/3/21 Legal Limitations on Appointment of New FDA Commissioner Read More
Analysis and Commentary 9/29/17 Analysis and Commentary 9/29/17 Plus ça Change, Plus c'est la Même Chose Read More
Analysis and Commentary 7/27/17 Analysis and Commentary 7/27/17 Challenges and Threats to FDA Resources: An Update Read More
Analysis and Commentary 10/30/15 Analysis and Commentary 10/30/15 So ... How Do We Help FDA Get a Fair Cut of the Extra $40 Billion? Read More
Advocacy at a Glance 10/9/15 Advocacy at a Glance 10/9/15 Will FSMA Make a Difference and more Read More
Advocacy at a Glance 10/2/15 Advocacy at a Glance 10/2/15 DA Science Board Report Calls for Funding to Meet Responsibilities and more Read More
Analysis and Commentary 5/1/15 Analysis and Commentary 5/1/15 FDA Funding and 21st Century Cures Read More
Analysis and Commentary 2/6/15 Analysis and Commentary 2/6/15 POTUS's FY 16 Budget Request ... On Careful Reflection Read More
